Sprouty 2 disturbs FGFR3 degradation in thanatophoric dysplasia type II: A severe form of human achondroplasia

Changsheng Guo, Catherine R. Degnin, Melanie B. Laederich, Gregory P. Lunstrum, Paul Holden, Jeanie Bihlmaier, Deborah Krakow, Yoon Jae Cho, William A. Horton

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Abstract

Thanatophoric dysplasia is a member of the achondroplasia family of human skeletal dysplasias, which result from FGFR3 mutations that exaggerate this receptor's inhibitory influence on chondrocyte proliferation and differentiation in the skeletal growth plate. We have previously reported that defective lysosomal degradation of activated receptor contributes to the gain-of-function of the mutant FGFR3. We now provide evidence that this disturbance is mediated by the receptor's kinase activity and involves constitutive induction and activation of Spry2. Our findings suggest that activated Spry2 may interfere with c-Cbl-mediated ubiquitination of FGFR3 by sequestering c-Cbl. They provide novel insight into the pathogenesis of this group of human skeletal dysplasias and identify a mechanism that potentially could be targeted therapeutically.

Original languageEnglish (US)
Pages (from-to)1471-1477
Number of pages7
JournalCellular Signalling
Volume20
Issue number8
DOIs
StatePublished - Aug 2008
Externally publishedYes

Keywords

  • Achondroplasia
  • FGFR3
  • RTK
  • Receptor degradation
  • Sprouty
  • Thanatophoric dysplasia
  • c-Cbl

ASJC Scopus subject areas

  • Cell Biology

Fingerprint

Dive into the research topics of 'Sprouty 2 disturbs FGFR3 degradation in thanatophoric dysplasia type II: A severe form of human achondroplasia'. Together they form a unique fingerprint.

Cite this